A phase 3, randomized, bouble-blind, active comparator study of the efficacy and safety of bBow015, a biosimilar infliximab, in patients with active rheumatoid arthritis on stable methotrexate doses
Titel:
A phase 3, randomized, bouble-blind, active comparator study of the efficacy and safety of bBow015, a biosimilar infliximab, in patients with active rheumatoid arthritis on stable methotrexate doses
Auteur:
Chopra, Arvind Kay, Jonathan Wyand, Michael S. Chandrashekara, S. Olakkengil, Avy J. Bhojani, Kaushik S. Bhatia, G. Rathi, Gaurav Thomas, Mathew Maroli, Suresh Thomson, Elizabeth Shneyer, Lucy